Camber Capital Management LP Eagle Pharmaceuticals, Inc. Transaction History

Camber Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $13.6 Million - $17 Million	-291,600 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$66.65 - $83.86 $2.03 Million - $2.56 Million	30,500 Added 11.68%	291,600 $20.2 Million
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $13.4 Million - $20 Million	261,100 New	261,100 $19.8 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Camber Capital Management LP with notifications on news.